Clinical Trials Browser

Uterine Anomalies, Endometriosis, Endometritis, Infertility, Infertility, Female, Leiomyoma, Polycystic Ovary Syndrome, Pregnancy, Ectopic, Salpingitis, Primary Ovarian Insufficiency

NCT05019846 2023-04-18

SPA

Phase 3 Recruiting

310 enrolled

Genitourinary

Prostatic Neoplasms

NCT00412022 2023-03-24

HOBOE

Phase 3 Unknown

1,294 enrolled

Breast

Breast Neoplasms

NCT04869371 2022-12-29

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Phase 2 Unknown

75 enrolled

Genitourinary

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

NCT05557604 2022-09-28

STUNNIN

Phase 2 Recruiting

146 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT02113553 2022-09-10

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Phase 2 Terminated

45 enrolled

Breast

Breast Neoplasms

NCT05212857 2022-03-16

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Phase 2 Unknown

160 enrolled

Genitourinary

Prostatic Neoplasms

NCT05112692 2021-11-09

Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

Phase NA Unknown

200 enrolled

Polycystic Ovary Syndrome

NCT04248621 2021-07-29

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Phase 4 Unknown

164 enrolled

Genitourinary

Prostatic Neoplasms

NCT00104741 2021-02-21

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 3 Completed

378 enrolled

Genitourinary

Prostatic Neoplasms

NCT04753177 2021-02-15

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Phase 2/3 Unknown

120 enrolled

The Neoadjuvant Therapy

NCT00090844 2021-01-28

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Phase 2 Terminated

49 enrolled 10 charts

Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04659551 2020-12-09

GIADA

Phase 2 Completed

43 enrolled

Breast

Breast Neoplasms

NCT02168062 2020-07-23

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

Phase 2 Terminated

57 enrolled 27 charts

Genitourinary

Prostate Adenocarcinoma

NCT02742675 2020-07-07

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Phase 2 Unknown

200 enrolled

Genitourinary

Prostatic Neoplasms

NCT02856048 2019-12-17

PRESOV

Phase 2/3 Unknown

11 enrolled

LymphoidSarcoma

Lymphoma, Neoplasms, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT01402336 2017-10-10

GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer

Phase 3 Completed

43 enrolled

Infertility, Polycystic Ovary Syndrome

NCT00194792 2017-07-11

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

Phase 2 Terminated

28 enrolled 9 charts

Breast

Breast Neoplasms

NCT01160315 2015-10-30

Erasme-POF

Phase 2/3 Completed

118 enrolled

Lymphoid

Lymphoma

NCT02102646 2015-10-28

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Phase 4 Completed

31 enrolled

Genitourinary

Fatty Liver, Hypogonadism, Prostatic Neoplasms, Metabolic Syndrome

NCT01873378 2015-08-11

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

Phase NA Completed

84 enrolled

Myofibroma

NCT02022228 2013-12-27

Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome

Phase NA Unknown

200 enrolled

Gynecologic

Infertility, Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome